Gene · 51592
Papers2,289
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,289
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Paraneoplastic Anti-transcriptional Intermediary Factor 1γ (Anti-TIF1γ)-Positive Dermatomyositis Presenting as Dropped Head Syndrome: A Case Report. | Cureus | 2025 | 40151720 | PubTator, text mining | PubMed |
| Plasma levels of adhesion molecules are elevated in dermatomyositis-interstitial lung disease and associated with low paraoxonase-1 activity. | Arthritis Res Ther | 2025 | 40055821 | PubTator, text mining | PubMed |
| Ultrasensitive interferons quantification reveals different cytokine profile secretion in inflammatory myopathies and can serve as biomarkers of activity in dermatomyositis. | Front Immunol | 2025 | 40013143 | PubTator, text mining | PubMed |
| Clinical Features of Dermatomyositis Associated with Myositis-Specific Antibodies in Moroccan Patients. | Clin Pract | 2025 | 39996701 | PubTator, text mining | PubMed |
| Comprehensive analysis of lncRNAs and mRNAs revealed potential participants in the process of avian reovirus infection. | Front Microbiol | 2025 | 39973927 | PubTator, text mining | PubMed |
| Discovery of myeloid zinc finger (MZF) 1 nuclear bodies. | Biochem Biophys Res Commun | 2025 | 39954358 | PubTator, text mining | PubMed |
| Association Between Anti-TIF1-γ Antibody and Triple-Negative Breast Carcinoma in Dermatomyositis Patients: A Case Report. | Clin Case Rep | 2025 | 39935654 | PubTator, text mining | PubMed |
| Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM study. | Rheumatology (Oxford) | 2025 | 39918968 | PubTator, text mining | PubMed |
| Unravelling the link: anti-TIF1γ dermatomyositis associated with plexiform neurofibroma. | Clin Exp Rheumatol | 2025 | 39907583 | PubTator, text mining | PubMed |
| Predictive value of myositis antibodies: role of semiquantitative classification and positivity for more than one autoantibody. | RMD Open | 2025 | 39837620 | PubTator, text mining | PubMed |
| [Cutaneous ulceration in dermatomyositis : Case reports with positive anti-NXP-2/anti-TIF1-gamma antibody status]. | Dermatologie (Heidelb) | 2025 | 39820721 | PubTator, text mining | PubMed |
| Established and novel insights to guide cancer assessment in patients with idiopathic inflammatory myopathies. | Semin Arthritis Rheum | 2025 | 39798246 | PubTator, text mining | PubMed |
| Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysis. | Alzheimers Dement | 2025 | 39711511 | PubTator, text mining | PubMed |
| Seasonal patterns of myositis-specific and myositis-associated autoantibodies in Italy: Seasonal patterns of myositis autoantibodies. | Immunol Lett | 2025 | 39681209 | PubTator, text mining | PubMed |
| Effective analysis of thyroid toxicity and mechanisms of acetyltributyl citrate using network toxicology, molecular docking, and machine learning strategies. | Toxicology | 2025 | 39657862 | PubTator, text mining | PubMed |
| The interplay between ECTO and ENDO exposomes on metabolic diseases throughout lifespan: exposome loop as a new concept. | J Endocrinol | 2025 | 39651729 | PubTator, text mining | PubMed |
| Pericardial artery lymphoma in a patient with dermatomyositis: A case report. | Mod Rheumatol Case Rep | 2025 | 39582206 | PubTator, text mining | PubMed |
| Anti-Sp4 and anti-CCAR1 autoantibodies in UK vs US patients with adult and juvenile-onset anti-TIF1γ-positive myositis. | Rheumatology (Oxford) | 2025 | 39514366 | PubTator, text mining | PubMed |
| Unilateral heliotrope rash: first sign of paraneoplastic anti-TIF1γ dermatomyositis. | Clin Exp Dermatol | 2025 | 39425680 | PubTator, text mining | PubMed |
| Myositis-specific and myositis-associated autoantibodies: their clinical characteristics and potential pathogenic roles. | Immunol Med | 2025 | 39394957 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51592/papers?page=8